USP To Discusss Methodology Behind Model Formulary Guidelines
This article was originally published in The Pink Sheet Daily
Executive Summary
The group willl review its proposal on drug categories and classes for Medicare plans and hear comment from PBMs and other stakeholders during an Aug. 27 meeting.